ISRCTN ISRCTN25005848
DOI https://doi.org/10.1186/ISRCTN25005848
Sponsor Imperial College London
Funders National Institute for Health and Care Research, Colt Foundation
Submission date
13/08/2026
Registration date
18/11/2026
Last edited
18/11/2026
Recruitment status
Not yet recruiting
Overall study status
Ongoing
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Silicosis is a chronic incurable but preventable lung disease caused by inhalation of silica dust at work when cutting and polishing stone. In early stages it does not cause any symptoms but over time can result in scarring and hardening of the lungs causing worsening breathlessness. Since 2010, there has been an increasing number of cases worldwide of silicosis in people working with artificial stone (which can contain very high silica levels) in the worktop fabrication industry. This study aims to understand how many people working in the UK worktop fabrication industry in the UK have silicosis or other silica related health conditions. It also aims to understand why some people develop silicosis and others do not.

Who can participate?
Workers at participating worktop fabrication companies with at least 1 year of exposure to stone dust.

What does the study involve?
This is an observational study which means we are not testing any new treatments. There are three parts to the baseline study:
1. Completion of a questionnaire which asks about current job, the jobs done in the past and also about health. This will be completed at work and answers will not be shared with the employer. It should take around 15-20 minutes to complete.
2. Participants will be invited to attend a local hospital for tests. This includes a chest x-ray, CT scan of the chest and blood and urine tests. The CT scan is the main test to see if there are signs of silica-related lung disease. All results will be shared with participants and appropriate follow up in NHS clinics arranged if needed.
3. Some participants will also be invited to have measurements of silica made whilst working over the course of 2 or 3 days. This involves wearing a personal sampling device to collect samples of the air present in the breathing zone (within about 20-30 cm from your nose and mouth). The sampler is usually positioned around the upper chest region and is attached using tubing to a lightweight pump to draw air through.
The follow up study will take place around 2 years later. Participants will be invited to complete a similar (shorter) questionnaire and attend a local hospital for the same repeat tests to see if there have been any changes.

What are the possible benefits and risks of participating?
The main benefit to participants is to have a health check including CT scan and blood tests. Silicosis does not cause any symptoms in the early stages. Therefore a worker could have silicosis and not realise it. The only way to detect it is to do a CT scan. If diagnosed with silicosis then we can provide best advice about how to reduce the chance of this getting worse.
The study will also provide information about why some workers develop silicosis and others do not. It will tell us if artificial stone can be used safely. It will also provide information about why some people with silicosis get disease which gets worse whilst other have silicosis which is stable. Finally, it will provide important information about silica levels in your workplace.
The main disadvantage to taking part in this study is that we may identify a medical issue or an abnormality that was not previously known about. This may or may not be related to silica exposure and further tests may be recommended to investigate these. If diagnosed with silicosis there is unfortunately no specific treatment available. However, the earlier it is picked up then the higher the chance of it remaining stable and not getting worse. Particularly if it is possible to stop being exposed to silica. For this reason, for workers diagnosed with silicosis we may advise that they change their job and this can be a difficult decision for some people. We can provide advice and support about this and other ways to keep healthy.
Blood sampling may cause brief discomfort when the needle is inserted. There is a small risk of bruising or minor bleeding at the site afterwards. Occasionally, people may feel faint or light-headed. Both chest x-rays and CT scan examinations use ionising radiation. The radiation dose from a chest X-ray is very low, while the CT scan involves a higher radiation exposure. The imaging protocols will keep radiation exposure as low as reasonably practicable while obtaining images of sufficient diagnostic quality.

Where is the study run from?
Researchers at Imperial College London (UK) are running the study but will visit participating workplaces around the country

When is the study starting and how long is it expected to run for?
January 2027 to January 2031

Who is funding the study?
National Institute for Health and Care Research (NIHR) (UK)

Who is the main contact?
Dr Johanna Feary, j.feary@imperial.ac.uk

Contact information

Dr Johanna Feary
Principal investigator, Public, Scientific

National Heart and Lung Institute
Guy Scadding Building
70 Cale Street
London
SW3 6PT
United Kingdom

ORCiD logoORCID ID 0000-0003-2903-6907
Phone +44 (0)2075947968
Email j.feary@imperial.ac.uk

Study information

Primary study designObservational
Observational study designCohort study
Scientific titleUnderstanding the epidemiology of ARTIficial STone: the ARTIST study
Study acronymARTIST
Study objectives
Ethics approval(s)

Not yet submitted

Health condition(s) or problem(s) studiedSilicosis
MethodologyRecruitment of a cohort of worktop fabricators at their workplaces. A cross-sectional study (comprising questionnaire, CT scan, chest x-ray, blood tests, urine tests) will be carried out. Participants will then be followed up at 2 years with repeated questionnaire and clinical measures. Exposure measurements to respirable crystalline silica will also be made on select workers in the cross-sectional study.
Intervention typeOther
Primary outcome measure(s)
  1. Prevalence of silicosis measured using CT scan at baseline
Key secondary outcome measure(s)
Completion date02/01/2031

Eligibility

Participant type(s)
Age groupMixed
Lower age limit18 Years
Upper age limit80 Years
SexAll
Target sample size at registration320
Key inclusion criteria1. Self-reported history of at least 6 months of exposure to silica in the worktop fabrication industry
2. Employed at contributing workplace
Key exclusion criteriaNot willing to consent
Date of first enrolment02/01/2027
Date of final enrolment02/01/2029

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centres

Royal Brompton Hospital
Sydney Street
London
SW3 6NP
England
Heartlands Hospital
Bordesley Green East
Bordesley Green
Birmingham
B9 5SS
England
Manchester University Hospital NHS Ft (hq)
Oxford Road
Manchester
M13 9WL
England

Results and Publications

Individual participant data (IPD) Intention to shareNo

Editorial Notes

01/10/2026: Study's existence confirmed by the NIHR.